A graphic from a recent amfAR report shows the potential loss of life because of across-the-board cuts, or sequestration. Research!America’s report on sequestration detailed the devastating impact that the sequester, or across-the-board cuts that are scheduled to take place in 2013, will have on federally funded research to improve health. Now, a recent report by amfAR trains the focus of sequestration on global health. Just as we found, amfAR reaches the same conclusion: Sequestration isn’t worth the cost. The cuts would save $689 million ’ or 0.63% of the required deficit reduction for FY13. And at what cost? HIV/AIDS treatment for 273,000 fewer people, potentially leading to 62,000...
Research!America is dedicated to ensuring a strong public and private sector investment in research to improve health at a level warranted by scientific opportunity and supported by public opinion. Member organizations and others share their perspectives on a wide variety of topics relating to public and private sector research and innovation, and public health. The views expressed by contributors are their own and not the view of Research!America.
Recent Blog Posts
By brianhunsicker on July 3, 2012
By brianhunsicker on June 28, 2012
By any measure, New York is one of the country’s top states for medical research and development: In FY11, the state attracted more than $2 billion across 4,606 awards from the National Institutes of Health. Only California and Massachusetts were better in either category. With robust academic research (not to mention a significant presence of independent research institutes, like Research!America members Cold Spring Harbor Laboratory and Masonic Medical Research Laboratory ) and NYC-based pharmaceutical giants Bristol-Myers Squibb and Pfizer , bioscience pays off for New York and its residents: According to a new report, the industry directly and indirectly supported 250,000 jobs across...
By researchamerica on June 28, 2012
Dear Research Advocate, Today, the Supreme Court surprised many in upholding most aspects of the Affordable Care Act. As the pundits and the blogosphere stoke continuing debate, candidates will stake out positions and policy makers will consider next steps. And everyone will have a point of view. As you express yours, I urge you to use a communication ’bridge’ to talk about the future of health and health care not only as an outcome of a court or legislative action, but as an outcome of research. Because of research, we live longer lives, death rates from heart disease have declined by 65% over the past 30 years, we don’t consider childhood cancer or HIV/AIDS a death sentence, and we...
By brianhunsicker on June 27, 2012
The following is a statement from Research!America President and CEO Mary Woolley on the Senate’s passage of FDA user fee legislation: “Senate approval of the FDA Safety and Innovation Act demonstrates the willingness of lawmakers to prioritize the health and safety of patients. The bipartisanship displayed in crafting and moving the bill through Congress underscores the strong support for bringing lifesaving treatments to patients in a safe, efficient and speedy manner. The additional funding for review of prescription drugs and medical devices, along with key policy changes, will accelerate the approval process and address issues that have for too long disrupted the flow of innovative new...
By brianhunsicker on June 26, 2012
Medical research is at risk in our nation. So too is prevention research, as well as the research needed to combat disease outbreaks, weed out costly inefficiencies and deadly errors from our health care system. Sequestration has already resulted in cuts to our federal health agencies; these cuts are on top of deep cuts already made to research. These continued cuts are stalling innovation and economic growth and discouraging the next generation of researchers and patients waiting for cures. If Congress continues to cut core federal functions, compromising our nation’s health and science agencies (National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug...
By brianhunsicker on June 26, 2012
To read our blog posts on global health, click here . Global and public health research and development (R&D) creates tools to combat killers like HIV/AIDS, malaria, tuberculosis and neglected tropical diseases. It is also a vehicle for job growth and generating economic activity here in the United States. Federal funding for global and public health R&D is the smart thing to do for the U.S. and the right thing to do for the world. To learn more about Research!America’s activities in global and public health R&D advocacy, see our website .
By researchamerica on June 25, 2012
Research!America has come out with a four-part ad series titled: ’Nice Save ’ American Ingenuity Saves Lives.’ The ads began running in Politico last week and continue this week; if you live in the D.C. region and ride Metro, you’ll also see these ads appearing on the red line , starting July 9. This global health R&D awareness campaign highlights the success and (sometimes unexpected) payoffs of investing in health and global health research. Please view the ad series and learn how you can make a difference here .
By researchamerica on June 25, 2012
Thanks for stopping by, and welcome to our humble new abode! After years of hosting a blog on our domain, we felt it was time to give our blog a fresh coat of paint and some new appliances. The end result is what you see here, and this will be the home of Research!America’s blog moving forward. Our old blog home will still live on as an archive, as we believe there is plenty of timeless and valuable information there. But we will no longer be adding new posts there. So please, take a look around and help us test the blinds. If you see something that’s not working as it should, please let us know by dropping an email to firstname.lastname@example.org . Again, thank you and welcome!
We NEED CURES, NOT CUTS. Sequestration arbitrarily stifles federal investment in national priorities like medical research and innovation, at the expense of America and Americans. Deficit reduction is important, but there are ways to achieve it that do not set out nation back, threatening our global leadership and shortchanging the health and safety of the American people.
On May 29, 2020, Research!America hosted an alliance member meeting with two distinguished representatives of the U.S. Department of Veterans Affairs (VA). Dr. Carolyn Clancy, Deputy Under Secretary for Discovery, Education and Affiliate Networks, and Dr. Rachel Ramoni, Chief Research and Development Officer, in concert, discussed the breadth of funding and capabilities that the VA has across the nation, presenting unique opportunities for innovative research that tackles disease in general, and as of late, responses specific to COVID-19. This is a summary of that meeting. The Veterans Health Administration has significant reach: 105 active research sites across the country, 7,372 funded...